0001012975-20-000678.txt : 20200812
0001012975-20-000678.hdr.sgml : 20200812
20200812172421
ACCESSION NUMBER: 0001012975-20-000678
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
EFFECTIVENESS DATE: 20200812
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCH VENTURE CORP
CENTRAL INDEX KEY: 0001274403
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19358
FILM NUMBER: 201096283
BUSINESS ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001274403
XXXXXXXX
06-30-2020
06-30-2020
ARCH VENTURE CORP
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO
IL
60631
13F HOLDINGS REPORT
028-19358
N
Mark McDonnell
Managing Director, CFO and CAO
773-380-6600
/s/ Mark McDonnell
Chicago
IL
08-12-2020
0
4
29724
false
INFORMATION TABLE
2
ARCH.xml
CHIASMA INC
COM
16706W102
6439
1196776
SH
SOLE
0
0
1196776
KURA ONCOLOGY INC
COM
50127T109
3363
206307
SH
SOLE
0
0
206307
RUBIUS THERAPEUTICS INC
COM
78116T103
15658
2618351
SH
SOLE
0
0
2618351
SYROS PHARMACEUTICALS INC
COM
87184Q107
4264
400000
SH
SOLE
0
0
400000